FR104E - - Google Patents
Info
- Publication number
- FR104E FR104E FR104DA FR104E FR 104 E FR104 E FR 104E FR 104D A FR104D A FR 104DA FR 104 E FR104 E FR 104E
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR104E true FR104E (de) |
Family
ID=1341612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR104D Active FR104E (de) |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR104E (de) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019241730A2 (en) | 2018-06-15 | 2019-12-19 | Flagship Pioneering Innovations V, Inc. | Increasing immune activity through modulation of postcellular signaling factors |
| WO2020203160A1 (ja) | 2019-03-29 | 2020-10-08 | 日東電工株式会社 | 積層体の製造方法、塗装物の製造方法、接合構造体の製造方法、熱転写シート、及び積層体 |
| WO2020227159A2 (en) | 2019-05-03 | 2020-11-12 | Flagship Pioneering Innovations V, Inc. | Methods of modulating immune activity |
| WO2021127217A1 (en) | 2019-12-17 | 2021-06-24 | Flagship Pioneering Innovations V, Inc. | Combination anti-cancer therapies with inducers of iron-dependent cellular disassembly |
| WO2021255447A1 (en) | 2020-06-16 | 2021-12-23 | Ucl Business Ltd | Follicular helper t cell profile for identifying patients with type 1 diabetes suitable fro treatment with ctla-4-ig |
| WO2022094391A2 (en) | 2020-11-02 | 2022-05-05 | Neuvogen, Inc. | Breast cancer tumor cell vaccines |
| WO2023014863A1 (en) | 2021-08-05 | 2023-02-09 | Go Therapeutics, Inc. | Anti-glyco-muc4 antibodies and their uses |
| WO2023034569A1 (en) | 2021-09-03 | 2023-03-09 | Go Therapeutics, Inc. | Anti-glyco-cmet antibodies and their uses |
| WO2023034571A1 (en) | 2021-09-03 | 2023-03-09 | Go Therapeutics, Inc. | Anti-glyco-lamp1 antibodies and their uses |
| WO2023077126A1 (en) | 2021-10-29 | 2023-05-04 | Tambo, Inc. | Trans-cyclooctene conjugates |
| WO2023077129A1 (en) | 2021-10-29 | 2023-05-04 | Tambo, Inc. | Tetrazine conjugates for in vivo targeted delivery of a payload |
| FR3135805A1 (fr) | 2022-05-23 | 2023-11-24 | Idemia France | Procédé de gestion de profils de service d’un élément sécurisé |
-
0
- FR FR104D patent/FR104E/fr active Active
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019241730A2 (en) | 2018-06-15 | 2019-12-19 | Flagship Pioneering Innovations V, Inc. | Increasing immune activity through modulation of postcellular signaling factors |
| WO2020203160A1 (ja) | 2019-03-29 | 2020-10-08 | 日東電工株式会社 | 積層体の製造方法、塗装物の製造方法、接合構造体の製造方法、熱転写シート、及び積層体 |
| WO2020227159A2 (en) | 2019-05-03 | 2020-11-12 | Flagship Pioneering Innovations V, Inc. | Methods of modulating immune activity |
| WO2021127217A1 (en) | 2019-12-17 | 2021-06-24 | Flagship Pioneering Innovations V, Inc. | Combination anti-cancer therapies with inducers of iron-dependent cellular disassembly |
| WO2021255447A1 (en) | 2020-06-16 | 2021-12-23 | Ucl Business Ltd | Follicular helper t cell profile for identifying patients with type 1 diabetes suitable fro treatment with ctla-4-ig |
| WO2022094391A2 (en) | 2020-11-02 | 2022-05-05 | Neuvogen, Inc. | Breast cancer tumor cell vaccines |
| WO2023014863A1 (en) | 2021-08-05 | 2023-02-09 | Go Therapeutics, Inc. | Anti-glyco-muc4 antibodies and their uses |
| WO2023034569A1 (en) | 2021-09-03 | 2023-03-09 | Go Therapeutics, Inc. | Anti-glyco-cmet antibodies and their uses |
| WO2023034571A1 (en) | 2021-09-03 | 2023-03-09 | Go Therapeutics, Inc. | Anti-glyco-lamp1 antibodies and their uses |
| WO2023077126A1 (en) | 2021-10-29 | 2023-05-04 | Tambo, Inc. | Trans-cyclooctene conjugates |
| WO2023077129A1 (en) | 2021-10-29 | 2023-05-04 | Tambo, Inc. | Tetrazine conjugates for in vivo targeted delivery of a payload |
| FR3135805A1 (fr) | 2022-05-23 | 2023-11-24 | Idemia France | Procédé de gestion de profils de service d’un élément sécurisé |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3962493A2 (de) | Verfahren zur modulation der immunreaktivität/konzentration von irf oder sting oder zur behandlung von krebs mit der verabreichung eines sting-modulators und/oder eines purinergischen rezeptormodulators oder eines postzellularen signalisierungsfaktors | |
| EP4076434A1 (de) | Kombination von antikrebstherapien mit induktoren der eisenabhängigen zellulären zerlegung | |
| JP2023509359A5 (de) | ||
| KR20210035805A (ko) | 세포후 신호전달 인자의 조절을 통한 면역 활성의 증가 | |
| JP2021528393A5 (de) | ||
| JP2024542021A (ja) | ペイロードのｉｎ ｖｉｖｏ標的化送達用のテトラジンコンジュゲート | |
| EP4422693A1 (de) | Trans-cycloocten-konjugate | |
| JP2024542021A5 (de) | ||
| JP2024543016A5 (de) | ||
| EP3950375A1 (de) | Verfahren zur herstellung eines laminierten körpers, verfahren zur herstellung eines lackierobjekts, verbindungsstrukturherstellungsverfahren, thermotransferfolie und laminierter körper | |
| CA3230933A1 (en) | Anti-glyco-lamp1 antibodies and their uses | |
| JP2024534910A5 (de) | ||
| CA3200513A1 (en) | Tumor cell vaccines | |
| FR104E (de) | ||
| EP4395810A1 (de) | Anti-glyco-cmet-antikörper und ihre verwendungen | |
| JP2024536722A5 (de) | ||
| CA3228178A1 (en) | Anti-glyco-muc4 antibodies and their uses | |
| JP2024531915A5 (de) | ||
| JP2025519087A (ja) | セキュアエレメントのサービスプロファイルを管理する方法 | |
| JP2025519087A5 (de) | ||
| EP4165405A1 (de) | Follikulares helfer-t-zellprofil zur identifizierung von patienten mit typ-1-diabetes zur behandlung mit ctla-4-ig |